wherein said administration provides for {HEAD ~ selective killing} of cancer cells by direct cytolysis and syncytia formation in cells that are susceptible to replication of {TAIL ~ the fusogenic mutant} HSV 2 
wherein said administration provides for { HEAD ~ selective killing } of cancer cells by direct cytolysis and syncytia formation in cells that are susceptible to replication of { TAIL ~ the fusogenic mutant } HSV 2
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH